Significant differences were found for age (69.54 vs. 73.43 years), HbA1c level (6.68% vs. 7.29%), years since diagnosis of type 2 diabetes mellitus (10.9 vs. 14.17), level of 25(OH)D (20.80 vs. 15.50 ng/mL), level of 1,25(OH)2D (35.0 vs. 24.5 pg/mL), patients receiving insulin (14.9% vs. 56.7%), hypertensive patients (77.7% vs. 100%), cardiovascular events (33.2% vs. 53.3%), and kidney failure (22.0% vs. 43.3%). This evidence concerns the gene INS and hypertensive disorder.